DYAX: Dyax Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DYAX: Dyax Corp.

DYAX 38.41

0.0%

Jan 25 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	5/20/2005 10:41:19 AM
	of 197

Dyax Announces Sale of Common Stock Thursday May 19, 2:36 pm ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 19, 2005--Dyax Corp. (Nasdaq:DYAX - News) announced today that it has entered into agreements to sell approximately 6,315,000 shares of its common stock to selected institutional and other accredited investors at $4.00 per share. The shares are being offered under Dyax's effective shelf registration statement previously filed with the Securities and Exchange Commission. Deutsche Bank Securities Inc. and SG Cowen & Co., LLC acted as placement agents for the offering. The net proceeds of the financing will be used for general corporate purposes, including funding Dyax's ongoing preclinical activities, clinical trials and operations....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next